Conversely, stabilization of Mcl1 protein by BAG3 and survival of BC and PC cells under ABT-737 stimulatory conditions has also been reported [105], highlighting a central but indirect and positive regulatory mechanism for the Mcl1 protein as a therapeutic resistance factor. The gene discussed is MCL1; the disease is breast cancer.